Brian M. Stolz - Net Worth and Insider Trading

Brian M. Stolz Net Worth

The estimated net worth of Brian M. Stolz is at least $10 Million dollars as of 2024-04-23. Brian M. Stolz is the Former Chief People Officer of Activision Blizzard Inc and owns about 108,041 shares of Activision Blizzard Inc (ATVI) stock worth over $10 Million. Brian M. Stolz is also the EVP, Administration and CHCO of Bausch Health Companies Inc and owns about 32,156 shares of Bausch Health Companies Inc (BHC) stock worth over $271,718. Details can be seen in Brian M. Stolz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian M. Stolz has not made any transactions after 2019-08-13 and currently still holds the listed stock(s).

Transaction Summary of Brian M. Stolz

To

Brian M. Stolz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian M. Stolz owns 3 companies in total, including BridgeBio Pharma Inc () , Activision Blizzard Inc () , and Bausch Health Companies Inc () .

Click here to see the complete history of Brian M. Stolz’s form 4 insider trades.

Insider Ownership Summary of Brian M. Stolz

Ticker Comapny Transaction Date Type of Owner
BridgeBio Pharma Inc 2019-10-09 Chief Operating Officer
Activision Blizzard Inc 2019-08-13 Chief People Officer
Bausch Health Companies Inc 2013-08-12 EVP & Administration&CHCO

Brian M. Stolz Latest Holdings Summary

Brian M. Stolz currently owns a total of 2 stocks. Among these stocks, Brian M. Stolz owns 108,041 shares of Activision Blizzard Inc (ATVI) as of August 13, 2019, with a value of $10 Million and a weighting of 97.41%. Brian M. Stolz also owns 32,156 shares of Bausch Health Companies Inc (BHC) as of August 12, 2013, with a value of $271,718 and a weighting of 2.59%.

Latest Holdings of Brian M. Stolz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATVI Activision Blizzard Inc 2019-08-13 108,041 94.42 10,201,231
BHC Bausch Health Companies Inc 2013-08-12 32,156 8.45 271,718

Holding Weightings of Brian M. Stolz


Brian M. Stolz Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian M. Stolz has made a total of 1 transactions in Activision Blizzard Inc (ATVI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Activision Blizzard Inc is the sale of 134,845 shares on August 13, 2019, which brought Brian M. Stolz around $6 Million.

According to the SEC Form 4 filings, Brian M. Stolz has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the acquisition of 4,500 shares on August 12, 2013, which cost Brian M. Stolz around $453,195.

Insider Trading History of Brian M. Stolz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian M. Stolz Trading Performance

GuruFocus tracks the stock performance after each of Brian M. Stolz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian M. Stolz is 7.81%. GuruFocus also compares Brian M. Stolz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian M. Stolz within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brian M. Stolz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brian M. Stolz

Average Return

36.76%

Average return per transaction

Outperforming Transactions

100%

6 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.36 7.81 21.57 36.76 56.73 27.92
Relative Return to S&P 500(%) 0.95 2.05 10.94 18.15 38.42 11.94

Brian M. Stolz Ownership Network

Ownership Network List of Brian M. Stolz

No Data

Ownership Network Relation of Brian M. Stolz


Brian M. Stolz Owned Company Details

What does BridgeBio Pharma Inc do?

Who are the key executives at BridgeBio Pharma Inc?

Brian M. Stolz is the Chief Operating Officer of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include Chairman of Oncology Frank Mccormick , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .

BridgeBio Pharma Inc () Insider Trades Summary

Over the past 18 months, Brian M. Stolz made no insider transaction in BridgeBio Pharma Inc (). Other recent insider transactions involving BridgeBio Pharma Inc () include a net sale of 1,034,094 shares made by Neil Kumar , a net sale of 412,388 shares made by Brian C Stephenson , and a net sale of 9,500 shares made by Randal W Scott .

In summary, during the past 3 months, insiders sold 2,500 shares of BridgeBio Pharma Inc () in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 3,064,727 shares of BridgeBio Pharma Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,064,727 shares.

BridgeBio Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BridgeBio Pharma Inc Insider Transactions

No Available Data

Brian M. Stolz Mailing Address

Above is the net worth, insider trading, and ownership report for Brian M. Stolz. You might contact Brian M. Stolz via mailing address: 2150 St. Elzear Blvd. West, Laval A8 H7l 4a8.

Discussions on Brian M. Stolz

No discussions yet.